ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,734Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 682

$608K Total Retail Price of All Prescriptions

Rank: 239 out of 682

629 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 9,329 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 515 404 1 4
LISINOPRIL 489 369 2 2
OMEPRAZOLE 463 353 3 5
AMLODIPINE BESYLATE 354 329 4 6
LEVOTHYROXINE SODIUM 339 264 5 3
FUROSEMIDE 328 297 6 7
CEFUROXIME 302 231 7 164
HYDROCHLOROTHIAZIDE 276 233 8 12
METOPROLOL SUCCINATE 245 194 9 16
METOPROLOL TARTRATE 236 214 10 10
METFORMIN HCL 236 179 10 8
GABAPENTIN 230 171 12 9
PREDNISONE 222 155 13 40
WARFARIN SODIUM 212 199 14 13
NEXIUM 198 144 15 19
ATORVASTATIN CALCIUM 175 149 16 11
LOSARTAN POTASSIUM 157 94 17 20
ENALAPRIL MALEATE 157 109 17 91
CLONIDINE HCL 148 107 19 48
ZETIA 135 114 20 69
POTASSIUM CHLORIDE 130 120 21 14
GLIPIZIDE 122 97 22 61
AMITRIPTYLINE HCL 119 98 R 23 50
AZITHROMYCIN 114 94 24 39
CITALOPRAM HBR 114 87 24 17
FLUOXETINE HCL 106 75 26 60
DONEPEZIL HCL 106 106 26 30
TRICOR 104 83 28 94
LANTUS 101 81 29 55
CARVEDILOL 93 69 30 23
POLYETHYLENE GLYCOL 3350 85 73 31 44
LOVAZA 79 36 32 106
GLYBURIDE 76 62 R 33 72
LOSARTAN-HYDROCHLOROTHIAZIDE 76 72 33 56
HYDROCODONE-ACETAMINOPHEN 75 66 S3 35 1
GLIPIZIDE ER 74 67 36 108
CIPROFLOXACIN HCL 73 58 37 58
ISOSORBIDE MONONITRATE ER 73 71 37 31
NAMENDA 72 72 39 41
NIFEDIPINE ER 71 45 40 144
LOVASTATIN 71 54 40 66
MELOXICAM 70 55 42 27
ATENOLOL 63 55 43 18
GLIMEPIRIDE 62 47 44 43
CLOPIDOGREL 60 36 45 25
DIGOXIN 59 59 46 46
JANUVIA 58 34 47 62
RAMIPRIL 58 57 47 81
METHYLPREDNISOLONE 58 44 47 127
ZOLPIDEM TARTRATE 58 43 47 21
PAROXETINE HCL 58 43 47 53
LANTUS SOLOSTAR 58 24 47 114
LEVOFLOXACIN 57 38 53 70
DIOVAN 56 54 54 42
METFORMIN HCL ER 54 44 55 68
ADVAIR DISKUS 51 42 56 47
VERAPAMIL ER 51 51 56 116
DILTIAZEM ER 50 41 58 136
LYRICA 50 49 58 78
MIRTAZAPINE 50 50 58 52
AMOX TR-POTASSIUM CLAVULANATE 50 41 58 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.